Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Orexo===OX640
Entity

Orexo===OX640

Tracked across 1 events · 7 articles · First seen Mar 06, 2026 · Last active Mar 06, 2026

Sentiment
20
Attention
2
Events
1
Relationships
4
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
2 20
Business
Orexo R&D Day on Strategy and AmorphOX
Orexo===OX640 is a powder-based intranasal epinephrine product candidate in development by Orexo for Type I allergic reactions, showcasing the application of Orexo===AmorphOX technology.
Mar 06, 2026 · 7 articles
Relationships (4)
Orexo===OX390 ↔ Orexo===OX640 Unknown
Orexo developer of ↔ Orexo===OX640 Orexo is developing Orexo===OX640, a powder-based intranasal epinephrine product
Nikolaj Sørensen ↔ Orexo===OX640 Unknown
Orexo===AmorphOX ↔ Orexo===OX640 Unknown
NEWSDESK
Track Orexo===OX640 live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.